BSR Endorses the GIRFT Paediatric Rheumatology Review

BSR is delighted to endorse the recently-published Getting It Right First Time (GIRFT) paediatric rheumatology review. G
Find out more

Michael Mason: The legacy behind BSR’s research award

Richard Michael Mason (1917–1977) helped shape the specialty during a period of rapid scientific and clinical development. His work continues to influence research, education and patient care across the UK.
Find out more

BSR 2025 Wrapped : Impact on our specialty

A year in review from BSR highlighting 2025 achievements in clinical guidance, research, education, data-driven service improvement and national policy influence, made possible through collaboration across the UK rheumatology community.
Find out more

National Early Inflammatory Autoimmune Diseases Audit (NEIAA) 2025 Highlights

Celebrate NEIAA’s 2025 achievements, including record patient recruitment, dashboard launch, published research, and audit expansion. Learn what’s next for NEIAA in 2026.
Find out more

Accessibility & Inclusion Support at BSR26

BSR is committed to making the Annual Conference accessible and inclusive for all delegates. We strive to ensure everyone can fully participate in our events, whether in person or online.
Find out more

Quality Improvement in Rheumatology: 5 tips inspired by the NEIAA

National audits such as the NEIAA help illuminate where to begin, giving visibility of strengths and clarity on where targeted improvement could make a real difference
Find out more

BSR26 Keynote Speakers Revealed: Highlights of Annual Conference 2026

BSR26 unveils its 2026 keynote speakers, including leaders in adult and paediatric rheumatology. Join the UK’s flagship rheumatology conference in Glasgow.
Find out more

Supporting you through winter: How BSR is empowering our community

Explore the winter pressures facing rheumatology teams, from infection risks to workforce challenges, and discover practical strategies and support from BSR.
Find out more

Updated csDMARDs guideline 2025 expands to all ages

We have published an updated evidence-based clinical guideline on the safe use of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARD) across the full spectrum of autoimmune rheumatic diseases.
Find out more

From curiosity to impact: Dr. Latika Gupta on building a career in clinical research

Dr. Latika Gupta shares her inspiring journey in clinical research, bridging patient care and science to advance understanding of autoimmune diseases.
Find out more